Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN110218229B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110218229B reveals a mild copper-catalyzed route for beta-mercapto azaphospho derivatives, offering safer manufacturing and cost reduction for pharmaceutical intermediates.